CONCOMITANT PATHOLOGY IN ADULTS WITH CONGENITAL HEART DISEASE, THE IMPACT ON HOSPITAL OUTCOMES CARDIOSURGERY TREATMENT
The number of grown-up patients with congenital heart is rising all over the world. This cohort of patients needs to be evaluated by cardiologists, and all of the types of the congenital heart, its complications and concomitant should be adjusted surgically. As the congenital heart is accompanied by congenital and acquired diseases, which has an affect on prognosis, and the end-points of the treatment, we have evaluated 605 grow-up patients, which have been hospitalized in a federal clinic with congenital heart in 2009. Out of the 605, male and female were 50.9% and 49.1% respectively, mean age 38.7, 42% of the total number of patients were socially active and 7.8% were disabled due to congenital heart. 17.9% of the patients have been operated on due to congenital heart, 60.3% were operated using extracorporeal blood circulation during the previous hospitalization. 36.7% were smokers (prevalence of smoking among male was higher), 35% of patients were overweight with BMI>25. 30% of patients had arrhythmias. Up to 60% patients appeared to have one or more concomintantacquired and/or congenital disease (male with more prevalence of MI and ulcer), in 46% of patients concomitant diseases, not related to congenital heart, needed additional diagnostic measures. Overall mortality during the operations under extracorporeal circulation and duration of treatment in patients with one or more concomitant disease or preoperational complication was higher comparing to those without any concomitant pathology. This should be taken in mind for budget planning and establishment of the standarts of patients care.